A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country

Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015

(2017) Christopher Troeger et al.   LANCET INFECTIOUS DISEASES

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

(2017) Odile Launay et al.   EBioMedicine

Shigella Vaccine Development: Finding the Path of Least Resistance

(2016) Wilbur H. Chen et al.   Clinical and Vaccine Immunology

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study

(2016) Mark S. Riddle et al.   Clinical and Vaccine Immunology

Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations

(2016) Luana Maggiore et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Haidong Wang et al.   LANCET

Status of vaccine research and development for Shigella

(2016) Sachin Mani et al.   VACCINE

Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza

(2016) Veronika I. Zarnitsyna et al.   PLoS Pathogens

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review

(2016) Vincent Muturi-Kioi et al.   PLoS One

Shift in serotype distribution of Shigella species in China, 2003–2013

(2015) S. Qiu et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery

(2015) Corinne N. Thompson et al.   PLoS Neglected Tropical Diseases

Failure of Syndrome-Based Diarrhea Management Guidelines to DetectShigellaInfections in Kenyan Children

(2015) P. B. Pavlinac et al.   Journal of the Pediatric Infectious Diseases Society

Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB

(2015) Christiane Gerke et al.   PLoS One

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

(2014) S. Livio et al.   CLINICAL INFECTIOUS DISEASES

Treatment of drug-resistantShigellainfections

(2014) Karl C Klontz et al.   Expert Review of Anti-Infective Therapy

Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study

(2014) Jie Liu et al.   LANCET INFECTIOUS DISEASES

Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies

(2014) Stefan Niewiesk   Frontiers in Immunology

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

(2013) Karen L Kotloff et al.   LANCET

Recent progress towards development of aShigellavaccine

(2012) Ana Isabel Camacho et al.   Expert Review of Vaccines

Race-specific WBC and neutrophil count reference intervals

(2010) E.-M. LIM et al.   International Journal of Laboratory Hematology

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa

(2009) Etienne Karita et al.   PLoS One